DANA-FARBER CANCER INSTITUTE
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1947-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.dana-farber.org/
Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation
- Conditions
- Interventions
- First Posted Date
- 2022-10-31
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 18
- Registration Number
- NCT05600101
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
- Conditions
- Interventions
- First Posted Date
- 2022-10-20
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 500
- Registration Number
- NCT05587439
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
UNTIRE: Cancer-related Fatigue with Digital Treatment
- Conditions
- Interventions
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 60
- Registration Number
- NCT05584540
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
PROFAST Intervention in Precursor Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2022-10-04
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 40
- Registration Number
- NCT05565638
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Drug Screening Using Novel IMD in ACC and Salivary Cancers
- Conditions
- Interventions
- First Posted Date
- 2022-09-23
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 20
- Registration Number
- NCT05553782
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 270
- Registration Number
- NCT05535192
- Locations
- 🇺🇸
Case Western Reserve University/University Hospitals Cleveland, Cleveland, Ohio, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 80
- Registration Number
- NCT05528263
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
The SPOT-HPV Study
- Conditions
- Interventions
- First Posted Date
- 2022-09-01
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 360
- Registration Number
- NCT05524025
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Brigham & Woman's Hospital, Boston, Massachusetts, United States
Cardiotoxicities in Patients Receiving BTKi
- Conditions
- Interventions
- First Posted Date
- 2022-08-30
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Dana-Farber Cancer Institute
- Registration Number
- NCT05521178
Sleep Treatment Education Program-1 (STEP-1)
- Conditions
- Interventions
- First Posted Date
- 2022-08-29
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 70
- Registration Number
- NCT05519982
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States